• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements].

作者信息

Kaufmann W, Butz P, Wiesendanger M

出版信息

Dtsch Z Nervenheilkd. 1970;197(1):85-100.

PMID:5522871
Abstract
摘要

相似文献

1
[Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements].[左旋多巴与脱羧酶抑制剂（Ro4-4602）联合治疗帕金森病患者的效果。通过反应时间测量对运动迟缓进行定量分析]
Dtsch Z Nervenheilkd. 1970;197(1):85-100.
2
[Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
Dtsch Z Nervenheilkd. 1969 Dec 29;197(1):85-100.
3
[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Rev Med Chil. 1973 Jun;101(6):452-5.
4
[Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)].
Wien Klin Wochenschr. 1969 Sep 26;81(39):677-9.
5
[Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].[左旋多巴治疗帕金森综合征以及左旋多巴与脱羧酶抑制剂联合使用]
Brux Med. 1972 Oct;52(10):673-80.
6
[Quantitative rigor determination in Parkinson's disease. Myo-integration for therapy control of L-Dopa in combination with a decarboxylase inhibitor (Ro 8-0576)].
Nervenarzt. 1974 Jan;45(2):22-9.
7
[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].口服左旋多巴联合脱羧酶抑制剂（Ro IV 46.02）治疗帕金森综合征
Presse Med (1893). 1969 Apr 5;77(17):619-22.
8
[Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].[左旋多巴与脱羧酶抑制剂（Ro 4-4602）治疗帕金森综合征。71例患者的病程]
Schweiz Med Wochenschr. 1972 Jan 22;102(3):88-94.
9
Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C.帕金森病中的外周芳香族L-氨基酸脱羧酶抑制剂。I. 对L-多巴-2-¹⁴C的O-甲基化代谢产物的影响
J Clin Invest. 1972 Feb;51(2):452-5. doi: 10.1172/JCI106831.
10
[Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor].
Minerva Med. 1972 Dec 12;63(89):4853-61.

引用本文的文献

1
[Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].帕金森病的鉴别治疗，特别提及医源性疾病的可能性（作者译）
Arch Psychiatr Nervenkr (1970). 1974 Apr 9;218(4):319-38. doi: 10.1007/BF00342576.
2
[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
Arch Psychiatr Nervenkr (1970). 1973 Mar 19;217(1):95-112. doi: 10.1007/BF02552835.
3
[The therapeutic effect of L-dopa].[左旋多巴的治疗效果]
Naturwissenschaften. 1972 Nov;59(11):492-6. doi: 10.1007/BF00609813.
4
Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.用左旋多巴和脱羧酶抑制剂治疗帕金森病。
Z Neurol. 1972;202(1):1-20. doi: 10.1007/BF00316422.
5
[Analysis of a rapid voluntary movement in Parkinsonian patients before and after stereotaxic thalamic lesions].[帕金森病患者立体定向丘脑损伤前后快速随意运动的分析]
Z Neurol. 1970;198(1):105-19.
6
[Delayed initiation of voluntary movements after pyramidal lesions in man (author's transl)].[人类锥体束损害后随意运动的延迟起始（作者译）]
Arch Psychiatr Nervenkr (1970). 1975 Dec 31;221(2):87-109. doi: 10.1007/BF00431047.